Arrowhead Pharmaceuticals (ARWR) Superinvestor holders
17 of the superinvestors we track hold Arrowhead Pharmaceuticals (ARWR) in their latest 13F filings, $659M in total.
Summary
The largest holder is Alger (Fred Alger Management), with $269M, 0.9% of the portfolio.
In their latest quarter: 4 opened a new position, 3 added, 9 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Alger Fred Alger Management |
Trimmed | 3,301,919 | $269M | 0.9% | Q2 2026 |
| Brandon Haley Holocene Advisors |
New position | 1,106,177 | $90M | 0.2% | Q2 2026 |
| Ken Fisher Fisher Investments |
Trimmed | 893,700 | $58M | 0.0% | Q3 2026 |
| Two Sigma Two Sigma Investments |
Added | 580,609 | $47M | 0.0% | Q2 2026 |
| Jim Simons Renaissance Technologies |
Trimmed | 468,921 | $38M | 0.1% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 431,560 | $35M | 0.0% | Q2 2026 |
| Artisan Partners | New position | 310,706 | $25M | 0.0% | Q2 2026 |
| Paul Marshall Marshall Wace |
Added | 305,031 | $25M | 0.0% | Q2 2026 |
| Arrowstreet Capital | Trimmed | 218,133 | $18M | 0.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | 198,842 | $16M | 0.0% | Q2 2026 |
| WCM Investment Management | Trimmed | 171,232 | $14M | 0.0% | Q2 2026 |
| Hersh Cohen ClearBridge Investments |
Trimmed | 157,110 | $13M | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
New position | 58,923 | $5M | 0.1% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Trimmed | 28,714 | $2M | 0.0% | Q2 2026 |
| Alan Breed Edgewood Management |
Held | 25,000 | $2M | 0.0% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Trimmed | 6,696 | $545,791 | 0.0% | Q2 2026 |
| Dan Davidowitz Polen Capital Management |
New position | 6,612 | $538,944 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 18 |
| Q1 2026 | 17 |
| Q4 2025 | 19 |
| Q3 2025 | 13 |
| Q2 2025 | 14 |
| Q1 2025 | 11 |
| Q4 2024 | 9 |
| Q3 2024 | 10 |
Questions about Arrowhead Pharmaceuticals
Which superinvestors own Arrowhead Pharmaceuticals?
17 of the superinvestors we track hold Arrowhead Pharmaceuticals (ARWR) in their latest 13F filings, $659M in total. Alger, Brandon Haley, Ken Fisher, Two Sigma, Jim Simons, David Shaw.
Who is the largest superinvestor holder of ARWR?
The largest holder is Alger (Fred Alger Management), with $269M, 0.9% of the portfolio.
From Arrowhead Pharmaceuticals's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.